metformin and naringenin

metformin has been researched along with naringenin in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's6 (50.00)24.3611
2020's5 (41.67)2.80

Authors

AuthorsStudies
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Choi, JS; Jung, HA; Min, BS; Paudel, P; Seong, SH1
Belury, MA; Purushotham, A; Tian, M1
Balk, B; Bujok, K; Fromm, MF; Glaeser, H; Mandery, K; Schmidt, I1
Malefane, TG; Ndwandwe, DE; Nyane, NA; Owira, PMO; Tlaila, TB1
Carani Venkatraman, A; Mutlur Krishnamoorthy, R1
Latiff, AA; Mardiana, AA; Sahema, ZCT; Santhana, RL; Syed Ahmad Fuad, SB; Zaidun, NH1
Essop, MF; Mato Mofo, EP; Owira, PMO1
Burade, V; Goswami, S; Pateliya, B2
Chai, HC; Chua, KH; Lim, SK; Mahendran, R; Ong, KC1
Bader, GN; Gupta, RK; Gupta, S; Jha, RK; Kawale, A; Rashid, R; Sarkar, S; Singh, A; Tripathi, R1

Reviews

2 review(s) available for metformin and naringenin

ArticleYear
Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.
    European journal of pharmacology, 2017, May-15, Volume: 803

    Topics: Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Flavanones; Humans; Hypoglycemic Agents; Metformin

2017
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.
    Clinical and experimental nephrology, 2021, Volume: 25, Issue:11

    Topics: Antioxidants; Chalcones; Curcumin; Diterpenes; Diterpenes, Kaurane; Emodin; Epoxy Compounds; Estrogen Antagonists; Flavanones; Humans; Hypoglycemic Agents; Metformin; Phenanthrenes; Plant Extracts; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; Quercetin; Resveratrol

2021

Other Studies

10 other study(ies) available for metformin and naringenin

ArticleYear
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Structure-related protein tyrosine phosphatase 1B inhibition by naringenin derivatives.
    Bioorganic & medicinal chemistry letters, 2017, 06-01, Volume: 27, Issue:11

    Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavanones; Hep G2 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Protein Conformation; Protein Tyrosine Phosphatase, Non-Receptor Type 1

2017
The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells.
    Molecular nutrition & food research, 2009, Volume: 53, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Flavanones; Glucose; Glucose-6-Phosphatase; Hypoglycemic Agents; Liver; Liver Neoplasms, Experimental; Metformin; Phosphatidylinositol 3-Kinases; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Signal Transduction

2009
Inhibition of hepatic uptake transporters by flavonoids.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, May-12, Volume: 46, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; Apigenin; Atorvastatin; Biological Transport; Flavanones; Flavonoids; Food-Drug Interactions; HEK293 Cells; Hepatocytes; Heptanoic Acids; Humans; Inhibitory Concentration 50; Kaempferols; Liver-Specific Organic Anion Transporter 1; Metformin; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 1; Pyrroles; Quercetin; Rutin; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfobromophthalein; Tritium

2012
Polyphenols activate energy sensing network in insulin resistant models.
    Chemico-biological interactions, 2017, Sep-25, Volume: 275

    Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Cell Differentiation; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Flavanones; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Metformin; Muscle Fibers, Skeletal; Palmitates; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Polyphenols; Quercetin; Rats; Rats, Wistar; Sirtuin 1

2017
Effects of naringenin on vascular changes in prolonged hyperglycaemia in fructose-STZ diabetic rat model.
    Drug discoveries & therapeutics, 2019, Volume: 13, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Drug Synergism; Flavanones; Fructose; Hyperglycemia; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Metformin; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin

2019
Citrus fruit-derived flavonoid naringenin and the expression of hepatic organic cation transporter 1 protein in diabetic rats treated with metformin.
    Basic & clinical pharmacology & toxicology, 2020, Volume: 127, Issue:3

    Topics: Animals; Blood Glucose; Citrus; Diabetes Mellitus, Experimental; Flavanones; Flavonoids; Hypoglycemic Agents; Lactic Acid; Liver; Male; Metformin; Organic Cation Transporter 1; Rats; Rats, Sprague-Dawley; Streptozocin

2020
Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo.
    European journal of pharmacology, 2021, Jan-15, Volume: 891

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Female; Flavanones; Humans; Interleukin-1beta; Male; Metformin; Mice, Inbred BALB C; Mice, Nude; Necrosis; Triple Negative Breast Neoplasms; Troponin I; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays

2021
Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Flavanones; Metformin; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; Tumor Burden

2021
Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:9

    Topics: Androgens; Animals; Disease Models, Animal; Female; Follicular Cyst; Humans; Letrozole; Metformin; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley

2023